April 24 (Reuters) - Delivra Corp DVA.V :
* DELIVRA CORP - ANNOUNCED ABILITY TO TREAT PAIN DIRECTLY WITH A TOPICAL VERSION OF ADVIL (IBUPROFEN)
* DELIVRA CORP - IN PRE-CLINICAL TESTING, DELIVRA-IBUPROFEN FORMULATION PROVIDED SUSTAINED PAIN REDUCTION